Agility announces updates regarding UnitedHealthcare.
Beginning June 1, UnitedHealthcare will no longer pay new or renewal commissions on Medicare Prescription Drug Plans. This effectively ends agent participation in the market through UnitedHealthcare products.
UnitedHealthcare is also announcing the end of lifetime commissions on its UnitedHealthcare AARP Medicare Supplement products in Florida, Maine, Maryland, New Mexico, and Texas. The end of commissions affects both new applications and internal replacements with signature dates on or after June 4, 2025, and an effective date of July 1, 2025, or later.
Commissions will be reallocated in Texas in years 8-10, and in Florida, Maine, Maryland, and New Mexico in years 7-10. The UnitedHealthcare AARP Medicare Supplement products are the only ones affected by this announcement, which was emailed to contracted agents in these states on May 20.
UnitedHealthcare Group (UHG) Chief Financial Officer John Rex revealed on last week’s earnings call that UHG will incorporate higher cost experiences and expectations into its 2026 Medicare Advantage bids, which are due to CMS soon. Medicare agents need to plan for reduced Medicare Advantage benefits from United in their higher-cost areas and be prepared for UnitedHealthcare to exit these areas entirely.
Scott Meeks, our Medicare product specialist, is here to answer your questions about how this news from UnitedHealthcare impacts the Medicare market and what agents’ next steps should be. Visit our Medicare contracting page now to find Prescription Drug Plan alternatives to contract with in your markets.
If needed, you can also see Medicare Supplement products available in Florida, Maine, Maryland, New Mexico, and Texas. You can contact Scott and Agility at (866) 590-9771 or email support@enrollinsurance.com for all insurance-related assistance. Agility can add you to our free weekly email list for tips and vital information.
Agility will inform you of the latest news from UnitedHealthcare and other Medicare payers as soon as possible.
